Vikrant Shrotriya
Tracked across 2 events · 14 articles · First seen Nov 11, 2025 · Last active May 25, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Vikrant Shrotriya, Managing Director of Novo Nordisk India, stated that the price revision aims to make Semaglutide more accessible to people in India.
Nov 11, 2025 · 6 articles
Business
Impact: Vikrant Shrotriya, Managing Director of Novo Nordisk India, commented on the price reductions, stating the company's aim to make treatments more affordable.
Mar 30, 2026 · 8 articles
ERGEN INTELLIGENCE
Track Vikrant Shrotriya live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard